649 related articles for article (PubMed ID: 33372174)
1. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling.
Zheng Y; Zhuang MW; Han L; Zhang J; Nan ML; Zhan P; Kang D; Liu X; Gao C; Wang PH
Signal Transduct Target Ther; 2020 Dec; 5(1):299. PubMed ID: 33372174
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.
Han L; Zhuang MW; Deng J; Zheng Y; Zhang J; Nan ML; Zhang XJ; Gao C; Wang PH
J Med Virol; 2021 Sep; 93(9):5376-5389. PubMed ID: 33913550
[TBL] [Abstract][Full Text] [Related]
3. Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.
Chang CY; Liu HM; Chang MF; Chang SC
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295922
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 NSP7 inhibits type I and III IFN production by targeting the RIG-I/MDA5, TRIF, and STING signaling pathways.
Deng J; Zheng Y; Zheng SN; Nan ML; Han L; Zhang J; Jin Y; Pan JA; Gao C; Wang PH
J Med Virol; 2023 Mar; 95(3):e28561. PubMed ID: 36755358
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation.
Wang W; Zhou Z; Xiao X; Tian Z; Dong X; Wang C; Li L; Ren L; Lei X; Xiang Z; Wang J
Cell Mol Immunol; 2021 Apr; 18(4):945-953. PubMed ID: 33637958
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Membrane Protein Inhibits Type I Interferon Production Through Ubiquitin-Mediated Degradation of TBK1.
Sui L; Zhao Y; Wang W; Wu P; Wang Z; Yu Y; Hou Z; Tan G; Liu Q
Front Immunol; 2021; 12():662989. PubMed ID: 34084167
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response.
Oh SJ; Shin OS
Cells; 2021 Mar; 10(3):. PubMed ID: 33801464
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules.
Zheng Y; Deng J; Han L; Zhuang MW; Xu Y; Zhang J; Nan ML; Xiao Y; Zhan P; Liu X; Gao C; Wang PH
Signal Transduct Target Ther; 2022 Jan; 7(1):22. PubMed ID: 35075101
[TBL] [Abstract][Full Text] [Related]
9. Differential roles of RIG-I like receptors in SARS-CoV-2 infection.
Yang DM; Geng TT; Harrison AG; Wang PH
Mil Med Res; 2021 Sep; 8(1):49. PubMed ID: 34488908
[TBL] [Abstract][Full Text] [Related]
10. RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses.
Kouwaki T; Nishimura T; Wang G; Oshiumi H
Front Immunol; 2021; 12():700926. PubMed ID: 34249006
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 NSP8 suppresses type I and III IFN responses by modulating the RIG-I/MDA5, TRIF, and STING signaling pathways.
Deng J; Zheng SN; Xiao Y; Nan ML; Zhang J; Han L; Zheng Y; Yu Y; Ding Q; Gao C; Wang PH
J Med Virol; 2023 Apr; 95(4):e28680. PubMed ID: 36929724
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7b-homologous interfering peptide.
Xiao X; Fu Y; You W; Huang C; Zeng F; Gu X; Sun X; Li J; Zhang Q; Du W; Cheng G; Liu Z; Liu L
J Virol; 2024 May; 98(5):e0157323. PubMed ID: 38572974
[TBL] [Abstract][Full Text] [Related]
13. Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets.
Yang Y; Ye F; Zhu N; Wang W; Deng Y; Zhao Z; Tan W
Sci Rep; 2015 Dec; 5():17554. PubMed ID: 26631542
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting RIG-I and MAVS To Evade the Innate Immune Response.
Liu Y; Qin C; Rao Y; Ngo C; Feng JJ; Zhao J; Zhang S; Wang TY; Carriere J; Savas AC; Zarinfar M; Rice S; Yang H; Yuan W; Camarero JA; Yu J; Chen XS; Zhang C; Feng P
mBio; 2021 Oct; 12(5):e0233521. PubMed ID: 34544279
[TBL] [Abstract][Full Text] [Related]
15. RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells.
Yamada T; Sato S; Sotoyama Y; Orba Y; Sawa H; Yamauchi H; Sasaki M; Takaoka A
Nat Immunol; 2021 Jul; 22(7):820-828. PubMed ID: 33976430
[TBL] [Abstract][Full Text] [Related]
16. Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3.
Lui PY; Wong LY; Fung CL; Siu KL; Yeung ML; Yuen KS; Chan CP; Woo PC; Yuen KY; Jin DY
Emerg Microbes Infect; 2016 Apr; 5(4):e39. PubMed ID: 27094905
[TBL] [Abstract][Full Text] [Related]
17. Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3.TANK.TBK1/IKKepsilon complex.
Siu KL; Kok KH; Ng MJ; Poon VKM; Yuen KY; Zheng BJ; Jin DY
J Biol Chem; 2009 Jun; 284(24):16202-16209. PubMed ID: 19380580
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-β Production.
Chen K; Xiao F; Hu D; Ge W; Tian M; Wang W; Pan P; Wu K; Wu J
Viruses; 2020 Dec; 13(1):. PubMed ID: 33396605
[TBL] [Abstract][Full Text] [Related]
19. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 main protease suppresses type I interferon production by preventing nuclear translocation of phosphorylated IRF3.
Fung SY; Siu KL; Lin H; Yeung ML; Jin DY
Int J Biol Sci; 2021; 17(6):1547-1554. PubMed ID: 33907518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]